Related Experiment Videos
Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report
1Department of Internal Medicine, Onomichi General Hospital, Hiroshima, Japan.
Japanese Heart Journal
|January 1, 1996
Abstract:
A 57-year-old woman with chronic hepatitis C was treated with alpha-2b interferon (IFN). Forty-five days after the initiation of IFN therapy, she developed cardiogenic shock. Acute perimyocarditis as a cause of cardiogenic shock was clinically suspected by the findings of complete atrioventricular block, regional wall motion abnormality and pericardial effusion. Since IFN therapy may induce cardiogenic shock in some patients, it is important to carefully monitor patients under treatment with IFN for abnormal cardiac signs.